Biodexa Pharmaceuticals Plc

US$2.48As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BDRXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (87.15%)
Div yield —
ROE (42.00%)
Biotechnology
Beta (5Y) 1.27
PE TTM —
TSR TTM (99.02%)
Mkt cap US$0.319M
ROIC (138.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.75
10.78%
(43.18%)
Hold 8|3|11|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.03
0.03
0.03
0.04
21.17%
22.58%
14.75%
13.42%
Revenue£M
0.025
0.026
0.026
0.026
1.46%
8.03%
7.25%
3.08%
Peers (US$0.319M)
Cap (US$)
PE
2.468M
—
2.387M
—
0.310M
1.003x
Capital
TTM
5Y
10Y
Leveragex
1.206
(0.355)
(0.214)
EBIT/Intx
1.844
0.545
0.489
Own earn%
116.07
(118.02)
(104.92)
Sh yield%
44.14
22.28
21.54
Owners
Insiders/Inst%
0.64
33.32
Short interest%
4.53
SBC / revenue%
5.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
19–28
$1 testx
0.3
Incr. ROIC%
3